• We incorrectly named one of the companies involved in the development of the CliniHub portable disease detector. The company is XenBio Fluidics (28 August, p 19).
• Further to the information we supplied on our Letters page about our neuromarketing study (21 August, p 26), we held a focus group for a selection of female New Scientist readers, which included discussion of cover designs.
